Issue 13, 2023

An iodide-containing covalent organic framework for enhanced radiotherapy

Abstract

Metal-free radiosensitizers, particularly iodine, have shown promise in enhancing radiotherapy due to their suitable X-ray absorption capacities and negligible biotoxicities. However, conventional iodine compounds have very short circulating half-lives and are not retained in tumors very well, which significantly limits their applications. Covalent organic frameworks (COFs) are highly biocompatible crystalline organic porous materials that are flourishing in nanomedicine but have not been developed for radiosensitization applications. Herein, we report the room-temperature synthesis of an iodide-containing cationic COF by the three-component one-pot reaction. The obtained TDI-COF can be a tumor radiosensitizer for enhanced radiotherapy by radiation-induced DNA double-strand breakage and lipid peroxidation and inhibits colorectal tumor growth by inducing ferroptosis. Our results highlight the excellent potential of metal-free COFs as radiotherapy sensitizers.

Graphical abstract: An iodide-containing covalent organic framework for enhanced radiotherapy

Supplementary files

Article information

Article type
Edge Article
Submitted
15 Jan 2023
Accepted
05 Mar 2023
First published
06 Mar 2023
This article is Open Access

All publication charges for this article have been paid for by the Royal Society of Chemistry
Creative Commons BY license

Chem. Sci., 2023,14, 3642-3651

An iodide-containing covalent organic framework for enhanced radiotherapy

L. Zhou, Q. Guan, W. Zhou, J. Kan and Y. Dong, Chem. Sci., 2023, 14, 3642 DOI: 10.1039/D3SC00251A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements